Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

A Cost-Effective Analysis of Interventions to Increase Repeat Testing in Patients Treated for Gonorrhea or Chlamydia at Public Sexually Transmitted Disease Clinics

October 3, 2005

Since persons who have been infected with chlamydia or gonorrhea (CT/GC) are at increased risk for reinfection, the authors of the current study sought to conduct a program- and societal-perspective cost-effectiveness analysis of five interventions designed to encourage public STD clinic patients to return for rescreening three months after initial treatment.

Cost data for the five interventions were collected at two STD clinics. These were combined with study data on return rates and CT/GC positivity rates among returning patients to compare the cost-effectiveness of the interventions.

"The cost per patient counseled with a brief recommendation to return, followed by a telephone reminder after three months, was higher than two interventions: a brief recommendation to return with no reminder and a $20 incentive, received on return," the researchers reported. Brief recommendation with a telephone reminder produced the highest return rate (33 percent) and was least costly in terms of cost per infection treated ($622 program, $813 societal). In-depth motivational counseling that helped patients identify risk factors and provided reasons for returning was costlier than a phone reminder alone and was no more effective.

Advertisement
"Phone reminders are more cost-effective than motivational counseling and improve return rates over a brief recommendation given at the time of initial treatment," the authors concluded.

Back to other news for October 3, 2005

Adapted from:
Sexually Transmitted Diseases
09.05; Vol. 32, No. 9: P. 542-549; Thomas L. Gift, Ph.D.; Kevin C. Malotte, Dr.P.H.; Rebecca Ledsky, M.B.A.; Matthew Hogben, Ph.D.; Susan Middlestadt, Ph.D.; Nancy L. VanDevanter, Dr.P.H.; Janet S. St. Lawrence, Ph.D.; The GCAP Study Group


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More HIV News
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement